openPR Logo
Press release

Remdesivir Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

06-09-2025 10:19 AM CET | Health & Medicine

Press release from: The Business Research Company

Remdesivir

Remdesivir

The Remdesivir Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Remdesivir Market Size and Projected Growth Rate?
The remdesivir market has experienced rapid growth in recent years. It will rise from $6.49 billion in 2024 to $8.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 31.2%. This growth is driven by the increasing prevalence of COVID-19, rising awareness of remdesivir, government support, clinical trials, and government purchases.

The remdesivir market is projected to grow rapidly to $15.91 billion in 2029 at a CAGR of 16.9%, with ongoing COVID-19 management, new virus strains, and pandemic readiness fueling demand. Main trends include combination therapy development, alternative antivirals, remote care, and broader use-case exploration.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3253

What Are the Major Segments in the Remdesivir Market?
The remdesivir market covered in this report is segmented -

1) By Route Of Administration: Oral, Intravenous
2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution
3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels

Subsegments:
1) By Oral: Tablet Formulation, Liquid Formulation
2) By Intravenous: Ready-To-Use Injectable, Lyophilized Powder For Injection

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp

What Are The Driving Remdesivir Market Evolution?
The remdesivir market is expected to grow due to increased government spending. Governments allocate funds to improve accessibility and research for antiviral medications like remdesivir, especially during health crises. According to the Government Digital Service in July 2023, the UK's government spending increased significantly, contributing to the market growth for remdesivir.

Which Firms Dominate The Remdesivir Market Segments?
Major companies operating in the remdesivir market include Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Pfizer Inc., Merck & Co. Inc., Cayman Chemical Company, Dr Reddy's Laboratories Ltd., Inovio Pharmaceuticals, Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Berry Global Group, Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories

What Are the Latest Developing Trends in the Remdesivir Market?
The high cost of certain drugs is expected to limit market growth. For instance, Gilead Sciences' remdesivir has a high estimated price, between $4,580 and $5,080 per treatment, which may hinder market growth. Despite initial donations, the company must charge for sustainable production, which contributes to the high cost, thus restricting the market's expansion.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/remdesivir-global-market-report

Which Is The Largest Region In The Remdesivir Market?
The countries covered in the remdesivir market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Remdesivir Market?
2. What is the CAGR expected in the Remdesivir Market?
3. What Are the Key Innovations Transforming the Remdesivir Industry?
4. Which Region Is Leading the Remdesivir Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Remdesivir Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis here

News-ID: 4056932 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Remdesivir

Remdesivir Market to Reach USD 2.1 Billion by 2034
Pune, India, November 11, 2025 - The global Remdesivir Market is projected to expand from USD 1.3 billion in 2024 to USD 2.1 billion by 2034, registering a CAGR of 4.9 %, according to Exactitude Consultancy. Although initially propelled by the COVID-19 pandemic, the market is now stabilizing as governments and healthcare systems maintain strategic antiviral reserves, and manufacturers reposition remdesivir for broader RNA-virus and pandemic-preparedness applications. Download Full PDF Sample
Remdesivir Production Cost Analysis Report by Procurement Resource
Procurement Resource, a leading name in procurement intelligence and market research, is pleased to release its latest Remdesivir Production Cost Report. This detailed report is a crucial tool for pharmaceutical companies, active pharmaceutical ingredient (API) manufacturers, investors, and regulatory stakeholders seeking to gain a deep understanding of the economics, technologies, and market trends behind the production of Remdesivir. Remdesivir Production Cost Analysis Report: https://www.procurementresource.com/production-cost-report-store/remdesivir With growing global interest in antiviral treatments and
Remdesivir Market Growth, Trends, and Opportunities From 2025-2034
On April 22,2025, Exactitude Consultancy., Ltd. released a research report titled "Medical Alert Systems Market". This report covers the global Medical Alert Systems market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along
Remdesivir Market Report 2024: Data-Driven Insights on Trends and Opportunities
It is a nucleoside analog with antiviral activity, with an EC50 value of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and an EC50 value of 30 for murine hepatitis virus in delayed brain tumor cells nM. 2024 Market Report by QYResearch "Remdesivir - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030" provides an extensive examination of Remdesivir market attributes, size assessments, and growth projections through
Remdesivir Market Trends, Strategies, And Outlook By 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2102 The Business Research Company offers in-depth market insights through Remdesivir Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The remdesivir market size has grown exponentially in recent years. It will grow
Remdesivir Drugs Market Development, Trends, Segmentations Analysis 2020-2030
Remdesivir Drugs Market Research Outlook The study on the remdesivir drugs market is based on robust data-driven research models to identify, understand, and draw insights on the tactical, operational, and strategic factors shaping the consumer needs, want, demands, and attitudes. The study uses industry-validated statistical methods to translate data into actional insights useful for accurate decision-making for the clients and customers. Remdesivir Drugs Market: Industry Trends and Value Chain The report on the